The Venture Codex Logo

The Venture Codex

Overview

Global chemical and pharmaceutical company with a long history.

Founded

1668

Deals ยท 12mo

6

Stage focus

Series B

Geographic focus

United States

Sector focus

Biotechnology
Health Care
Life Science
Manufacturing
...

Investment portfolio

100rounds
NAMEDATESIZE
BigHat Biosciences
Sep 2026Participated
$75 MSeries C
N-Power Medicine
Sep 2026Participated
$32 MSeries B
Faro AI, Inc.
Aug 2026Led
$37 MSeries B
Infinimmune
Aug 2026Participated
$75 MSeries A
Unnatural Products
Mar 2026Participated
$45 MSeries B
Cassidy Bio
Nov 2025Participated
$8 MSeed
Octave
Sep 2025Participated
$51 MSeries C
PreciseDx
Jun 2025Led
$11 MOther Equity
Variational AI
Feb 2025Participated
$6 MSeed
Ambrosia Biosciences
Dec 2024Led
$25 MSeries A
DANNCE.AI
Nov 2024Participated
$3 MSeed
Qure AI
Sep 2024Participated
$65 MSeries D
BigHat Biosciences
Sep 2026Participated
$75 MSeries C
N-Power Medicine
Sep 2026Participated
$32 MSeries B
Faro AI, Inc.
Aug 2026Led
$37 MSeries B
Infinimmune
Aug 2026Participated
$75 MSeries A
Unnatural Products
Mar 2026Participated
$45 MSeries B
Cassidy Bio
Nov 2025Participated
$8 MSeed
Octave
Sep 2025Participated
$51 MSeries C
PreciseDx
Jun 2025Led
$11 MOther Equity
Variational AI
Feb 2025Participated
$6 MSeed
Ambrosia Biosciences
Dec 2024Led
$25 MSeries A
DANNCE.AI
Nov 2024Participated
$3 MSeed
Qure AI
Sep 2024Participated
$65 MSeries D
100
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Merck: 100 funding rounds are recorded in the selected participation categories.All available history.
Merck: 100 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed04
Series A210
Series B820
Series C+814
Other Equity1419
Debt01

Monthly Deal Activity

Merck: 100 deals are recorded across 190 months.All available history.
Merck: 100 deals are recorded across 190 months. All available history
MonthDeals
Jan '111
Feb '110
Mar '110
Apr '110
May '110
Jun '110
Jul '110
Aug '110
Sep '110
Oct '110
Nov '110
Dec '112
Jan '121
Feb '120
Mar '120
Apr '120
May '120
Jun '120
Jul '120
Aug '120
Sep '121
Oct '120
Nov '121
Dec '120
Jan '132
Feb '130
Mar '130
Apr '130
May '130
Jun '131
Jul '130
Aug '130
Sep '131
Oct '130
Nov '130
Dec '132
Jan '141
Feb '140
Mar '140
Apr '141
May '141
Jun '140
Jul '141
Aug '141
Sep '141
Oct '142
Nov '140
Dec '140
Jan '150
Feb '151
Mar '151
Apr '151
May '151
Jun '150
Jul '152
Aug '151
Sep '151
Oct '152
Nov '150
Dec '151
Jan '160
Feb '162
Mar '160
Apr '161
May '160
Jun '160
Jul '161
Aug '160
Sep '160
Oct '160
Nov '160
Dec '160
Jan '171
Feb '170
Mar '170
Apr '171
May '170
Jun '171
Jul '170
Aug '170
Sep '173
Oct '170
Nov '172
Dec '171
Jan '180
Feb '180
Mar '180
Apr '181
May '181
Jun '180
Jul '181
Aug '180
Sep '180
Oct '180
Nov '181
Dec '180
Jan '190
Feb '190
Mar '191
Apr '190
May '190
Jun '190
Jul '191
Aug '190
Sep '191
Oct '190
Nov '191
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '201
Jun '200
Jul '204
Aug '200
Sep '203
Oct '200
Nov '201
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '213
Jul '211
Aug '210
Sep '210
Oct '212
Nov '210
Dec '212
Jan '223
Feb '222
Mar '221
Apr '220
May '220
Jun '221
Jul '221
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '231
Apr '230
May '231
Jun '230
Jul '231
Aug '231
Sep '230
Oct '230
Nov '232
Dec '231
Jan '240
Feb '240
Mar '240
Apr '240
May '242
Jun '241
Jul '240
Aug '241
Sep '241
Oct '240
Nov '241
Dec '241
Jan '250
Feb '251
Mar '250
Apr '250
May '250
Jun '251
Jul '250
Aug '250
Sep '251
Oct '250
Nov '251
Dec '250
Jan '260
Feb '260
Mar '261
Apr '260
May '260
Jun '260
Jul '260
Aug '262
Sep '262
Oct '260

Sector Breakdown

Merck: Health & Life Sciences is the largest displayed sector by deal count (92 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Merck: Health & Life Sciences is the largest displayed sector by deal count (92 deals). All available history
SectorDeals
Health & Life Sciences92
Data, Analytics & IT15
Enterprise Software14
AI & Machine Learning14
Networks, Cloud & Communication11
Professional Services10
Cybersecurity & Privacy6
Space & Frontier Tech6
Transportation & Logistics3
Hardware & Robotics3
Developer Tools3
Consumer & Lifestyle2
Marketing & Advertising2
Manufacturing2
Media & Entertainment2
Fintech1

Deal Size Distribution

Merck: 100 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Merck: 100 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M3
$5M-$10M17
$10M-$25M32
$25M-$50M25
$50M-$100M15
$100M-$250M7
$250M-$500M1
$500M-$1B0
$1B+0

Deals By Geography

Merck: United States has the largest recorded deal count among the displayed regions (87 deals).All available history.

Top 7 of 7 regions; European countries are grouped as Europe.

Merck: United States has the largest recorded deal count among the displayed regions (87 deals). All available history
RegionDeals
United States87
Europe7
Canada2
Israel1
018671
336371
India1
Merck: 20 co-investors are shown, with Amgen Ventures sharing 8 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Investment Strategy

Merck: Led accounts for 32% and participating for 68% of round participation.All available history.
Merck: Led accounts for 32% and participating for 68% of round participation. All available history
CategoryDeals (count)Share (%)
Led3232%
Participating6868%
Merck: Single-lead accounts for 53% and co-led for 47% of lead dynamics.All available history.
Merck: Single-lead accounts for 53% and co-led for 47% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1753%
Co-led1547%

Team

Andrea Herrmann

Associate Director, Strategy Implementation Leader

Anna Lena Fritzsche

Manager People Analytics Consultancy & Organization Development

Bernd Reckmann

Head of Chemicals

Craig Roberts

AVP, Vaccines, Center for Observational and Real-World Evidence

David M. Rubin

Managing Director

David Weinreich

Executive Vice President, Head, Global Clinical Development

Karim Bendhaou

Head of Africa Affairs

Raymond Behrendt

R&D Manager

Uwe Gudat

Head of Safety Biosimilars